HØRSHOLM, DK / ACCESS Newswire / June 30, 2025 / Gubra (CPH:GUBRA) Today, 30 June 2025, Gubra shares are traded ex-dividend of DKK 61.20. Contacts at Gubra Media: Sofia Pitt Boserup, [email protected] ...

Gubra, founded in 2008 in Denmark, listed on Nasdaq Copenhagen, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases.

HØRSHOLM, DK / ACCESS Newswire / June 30, 2025 / Gubra (CPH:GUBRA) Today, 30 June 2025, Gubra shares are traded ex-dividend of DKK 61.20. Contacts at Gubra Media: Sofia Pitt Boserup, [email protected] , ...

Gubra, founded in 2008 in Denmark, listed on Nasdaq Copenhagen, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases.

Contacts at Gubra Media: Sofia Pitt Boserup, [email protected], +45 4188 9586 Investors: Kristian Borbos, [email protected], +45 3080 8035 About Gubra Gubra, founded in 2008 in Denmark, listed on Nasdaq ...

Contacts at Gubra Media: Sofia Pitt Boserup, [email protected], +45 4188 9586 Investors: Kristian Borbos, [email protected], +45 3080 8035 About Gubra ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...

Gubra Announces Positive GUBamy Phase 1 Interim MAD Results HØRSHOLM, DK / ACCESS Newswire / April 1, 2025 / Gubra (CPH:GUBRA) GUBamy was well tolerated with adverse events being predominantly GI ...

Under terms of the deal, AbbVie will acquire Capstan’s lead asset, CPTX2309—an in vivo anti-CD19 CAR T-cell therapy in Phase ...